Skip to content

Resolution of Graves disease pathophysiology by flowcytometrey

Resolution of Graves disease pathophysiology by flowcytometrey - Resolution of Graves disease pathophysiology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000017726
Enrollment
100
Registered
2015-06-01
Start date
2015-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves disease

Interventions

None listed

Sponsors

University of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have not received the treatment for Graves' disease Age: 20 years of age and older. It does not matter gender. Patients who agree with this study

Exclusion criteria

Exclusion criteria: Patients who refuse this study Any patients whom the investigators judged to be inappropriate for this study

Design outcomes

Primary

MeasureTime frame
Subset analysis of the abnormalities and changes after treatment of immunocompetent cells (T cell, B cell, dendritic cell, monocyte, macrophage, and natural killer cell) in Graves' disease.

Countries

Japan

Contacts

Public ContactKeiichi Torimoto

University of Occupational and Environmental Health First Department of Internal Medicine, School of Medicine

torimoto@med.uoeh-u.ac.jp093-603-1611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026